About The Medical Condition EN1639A

ClusterMed

Find the definition of the medical term EN1639A. EN1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

EN1639A

EN1639A Medical Condition Defined & Explained
EN1639A Medical Condition

What's The Definition Of The Medical Condition EN1639A?

Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day

  • Vascular Dementias, Subcortical ‐ An imprecise term refering to dementia associated with CEREBROVASCULAR…
  • Puromycin Hydrochloride ‐ An antibiotic from Streptomyces alboniger that inhibits protein…
  • Chains, Food ‐ The sequence of transfers of matter and energy from organism…
  • Apoptosis ‐ One of the two mechanisms by which CELL DEATH occurs (the other…
  • Meprin ‐ Sulfhydryl acylated derivative of glycine used in treatment of…
  • Youth, Street ‐ Runaway and homeless children and adolescents living on the streets…
  • Feline Distempers ‐ A highly contagious DNA virus infection of the cat family and…
  • Genes, Neurofibromatosis 1 ‐ Tumor suppressor genes located on the long arm of human chromosome…
  • Neurilemmomas, Acoustic ‐ A schwannoma that arises from the vestibular division of the…
  • Aid, Foreign ‐ The interaction of persons or groups of persons representing…